BlossomHill Therapeutics, Inc. (BLSM) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-18
4:53 pm
Purchase
2026-08-1013DBLOSSOMHILL THERAPEUTICS INC C
BLSM
ORBIMED ADVISORS LLC2,714,279
8.900%
2,714,279increase
(New Position)
Filing
History
2026-08-17
3:46 pm
Purchase
2026-08-1013GBLOSSOMHILL THERAPEUTICS INC C
BLSM
Vivo Innovation Fund II Holdings, L.P.1,681,240
5.500%
1,681,240increase
(New Position)
Filing
History
2026-08-14
5:18 pm
Purchase
2026-08-0713GBLOSSOMHILL THERAPEUTICS INC C
BLSM
Perceptive Advisors LLC1,808,533
5.900%
1,808,533increase
(New Position)
Filing
History
2026-08-13
4:12 pm
Purchase
2026-08-0613DBLOSSOMHILL THERAPEUTICS INC C
BLSM
Cormorant Asset Management, LP3,615,362
11.800%
3,615,362increase
(New Position)
Filing
History